Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $1,701 | 11 | 79.1% |
| Food and Beverage | $450.40 | 20 | 20.9% |
Payments by Type
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $1,701 | 11 | $0 (2024) |
| Novo Nordisk Inc | $148.25 | 3 | $0 (2022) |
| Corcept Therapeutics | $67.67 | 3 | $0 (2023) |
| Horizon Therapeutics plc | $52.00 | 3 | $0 (2023) |
| Insulet Corporation | $40.58 | 2 | $0 (2024) |
| Dexcom, Inc. | $33.43 | 2 | $0 (2023) |
| Abbott Laboratories | $32.25 | 2 | $0 (2023) |
| PFIZER INC. | $18.00 | 1 | $0 (2023) |
| Xeris Pharmaceuticals, Inc. | $17.79 | 1 | $0 (2022) |
| Amryt Pharma Holdings Ltd | $16.56 | 1 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,732 | 13 | ABBVIE INC. ($1,701) |
| 2023 | $149.50 | 8 | Corcept Therapeutics ($67.67) |
| 2022 | $269.96 | 10 | Novo Nordisk Inc ($148.25) |
All Payment Transactions
31 individual payment records from CMS Open Payments — Page 2 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 06/15/2022 | Xeris Pharmaceuticals, Inc. | GVOKE PFS (Drug) | Food and Beverage | In-kind items and services | $17.79 | General |
| Category: Diabetes | ||||||
| 04/13/2022 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $9.35 | General |
| 04/06/2022 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $19.34 | General |
| Category: Endocrinology | ||||||
| 03/31/2022 | Novo Nordisk Inc | Rybelsus (Drug) | Food and Beverage | In-kind items and services | $120.83 | General |
| Category: Diabetes | ||||||
| 03/08/2022 | Amryt Pharma Holdings Ltd | MYCAPSSA (Drug) | Food and Beverage | In-kind items and services | $16.56 | General |
| Category: Endocrinology | ||||||
| 02/23/2022 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $18.07 | General |
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| A Phase 2/3 Multicenter, Double Blinded, Randomized, Dose-conversion, Active Control Study Examining the Efficacy and Safety of Armour Thyroid Compared to Synthetic T4 for the Treatment of Adults With Primary Hypothyroidism | ABBVIE INC. | $1,701 | 11 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 6 | 156 | 264 | $29,219 | $12,467 |
| 2022 | 5 | 98 | 183 | $23,147 | $7,960 |
| 2021 | 4 | 130 | 252 | $46,132 | $11,014 |
| 2020 | 6 | 251 | 537 | $120,350 | $28,116 |
All Medicare Procedures & Services
21 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 41 | 45 | $9,675 | $4,251 | 43.9% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 34 | 67 | $8,040 | $3,761 | 46.8% |
| 99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 32 | 69 | $6,693 | $2,535 | 37.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 18 | 25 | $3,732 | $1,573 | 42.1% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 18 | 31 | $620.00 | $260.40 | 42.0% |
| 82962 | Blood glucose (sugar) test performed by hand-held instrument | Office | 2023 | 13 | 27 | $459.00 | $86.67 | 18.9% |
| 99231 | Follow-up hospital inpatient care per day, typically 15 minutes | Facility | 2022 | 33 | 94 | $9,252 | $2,769 | 29.9% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 21 | 21 | $4,515 | $2,103 | 46.6% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 18 | 36 | $6,514 | $1,872 | 28.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 13 | 18 | $2,628 | $1,172 | 44.6% |
| 82962 | Blood glucose (sugar) test performed by hand-held instrument | Office | 2022 | 13 | 14 | $238.00 | $45.12 | 19.0% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 30 | 90 | $18,588 | $4,896 | 26.3% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Facility | 2021 | 72 | 79 | $16,590 | $2,643 | 15.9% |
| 99231 | Subsequent hospital inpatient care, typically 15 minutes per day | Facility | 2021 | 14 | 69 | $6,719 | $2,042 | 30.4% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2021 | 14 | 14 | $4,235 | $1,433 | 33.8% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 75 | 265 | $55,650 | $14,704 | 26.4% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Facility | 2020 | 104 | 171 | $35,910 | $5,542 | 15.4% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2020 | 17 | 41 | $11,890 | $3,350 | 28.2% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2020 | 21 | 22 | $8,580 | $2,277 | 26.5% |
| 99221 | Initial hospital inpatient care, typically 30 minutes per day | Facility | 2020 | 23 | 23 | $6,670 | $1,782 | 26.7% |
| 99231 | Subsequent hospital inpatient care, typically 15 minutes per day | Facility | 2020 | 11 | 15 | $1,650 | $461.21 | 28.0% |
About Dr. Helmut Steinberg, M.D
Dr. Helmut Steinberg, M.D is a Endocrinology, Diabetes & Metabolism healthcare provider based in Memphis, Tennessee. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/18/2006. The National Provider Identifier (NPI) number assigned to this provider is 1467417246.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Helmut Steinberg, M.D has received a total of $2,152 in payments from pharmaceutical and medical device companies, with $1,732 received in 2024. These payments were reported across 31 transactions from 12 companies. The most common payment nature is "" ($1,701).
As a Medicare-enrolled provider, Steinberg has provided services to 635 Medicare beneficiaries, totaling 1,236 services with total Medicare billing of $59,557. Data is available for 4 years (2020–2023), covering 21 distinct procedure/service records.
Practice Information
- Specialty Endocrinology, Diabetes & Metabolism
- Other Specialties Diabetes & Metabolism|Endocrinology, Diabetes & Metabolism
- Location Memphis, TN
- Active Since 04/18/2006
- Last Updated 02/25/2025
- Taxonomy Code 207RE0101X
- Entity Type Individual
- NPI Number 1467417246
Products in Payments
- ARMOUR THYROID (Drug) $1,701
- Rybelsus (Drug) $120.83
- Korlym (Drug) $67.67
- Omnipod (Device) $40.58
- Dexcom G6 Transmitter (Medical Supply) $33.43
- FREESTYLE LIBRE (Device) $32.25
- SOMAVERT (Drug) $18.00
- GVOKE PFS (Drug) $17.79
- MYCAPSSA (Drug) $16.56
- MINIMED 770G (Device) $14.43
- CeQur Simplicity (Device) $9.44
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Endocrinology, Diabetes & Metabolism Doctors in Memphis
Alan Cohen, M.d, M.D
Endocrinology, Diabetes & Metabolism — Payments: $1.8M
Dr. Shimon Harary, Md, MD
Endocrinology, Diabetes & Metabolism — Payments: $791,290
Dr. Samuel Dagogo-Jack, Md, MD
Endocrinology, Diabetes & Metabolism — Payments: $621,268
Dr. Aidar Gosmanov, M.d., Ph.d, M.D., PH.D
Endocrinology, Diabetes & Metabolism — Payments: $314,600
Dr. Malini Gupta, M.d, M.D
Endocrinology, Diabetes & Metabolism — Payments: $64,680
Dr. Maher Ghawji, M.d, M.D
Endocrinology, Diabetes & Metabolism — Payments: $15,733